Results 191 to 200 of about 95,168 (297)

Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic Republic of Congo: A Randomised, Controlled Trial. [PDF]

J Viral Hepat
Tulenko SE, Ngimbi P, Mwandagalirwa K, Tabala M, Matondo J, Ntambua S, Mbonze N, Mbendi C, Luhata C, Jhaveri R, Edwards JK, Becker-Dreps S, Moormann AM, Kaba D, Yotebieng M, Parr JB, Gower EW, Thompson P.   +17 more
europepmc   +1 more source

The State of Hepatitis B in Florida in 2025: Current Challenges and Health Disparities

Journal of Viral Hepatitis, Volume 33, Issue 2, February 2026.
ABSTRACT Hepatitis B virus (HBV) infection remains a significant public health challenge in Florida despite advancements in prevention and treatment. This review analyses the current epidemiology, disease burden and management strategies for hepatitis B in Florida as of 2025, drawing on state surveillance data and recent public health reports.
Cameron Nejat
wiley   +1 more source

The Effect of Physical Disability on Employment

Scottish Journal of Political Economy, Volume 73, Issue 1, February 2026.
ABSTRACT The relationship between physical disability and employment is explored using microdata for older working‐age women in the 2016 Irish Census of Population and historical data on the incidence of infectious diseases. Two‐stage least squares and recursive bivariate probit estimations are employed to account for the potential endogeneity of ...
Irene Mosca
wiley   +1 more source

The Predictive Role of miRNAs in Hepatitis B Vaccine Response of Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. [PDF]

Viruses
Guney Eskiler G, Karabay O, Tozlu M, Aydin A, Hamarat KF, Alkurt U, Deveci Ozkan A, Gunduz Y.   +7 more
europepmc   +1 more source

Bee products as alternatives in the treatment of viral infections

Journal of the Science of Food and Agriculture, Volume 106, Issue 1, Page 33-54, 15 January 2026.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba, Łukasz Marek, Jerzy Stojko, Anna Rzepecka‐Stojko   +3 more
wiley   +1 more source

Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine

, 2015
Saqib Walayat
openalex   +2 more sources

European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions

Molecular Oncology, Volume 20, Issue 1, Page 96-116, January 2026.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts, Paul Bloem, Silvia de Sanjosé, Sophie Grabar, Marcis Leja, Peter Malfertheiner, Mojca Matičič, Francis Mégraud, Francesco Negro, Martyn Plummer, Maarten Schim van der Loeff, Graciela Balbín, Josefina Salazar, Hajo Zeeb, Ariadna Feliu, Erica D'Souza, David Ritchie, Carolina Espina, Silvia Franceschi   +18 more
wiley   +1 more source

Lower Motor Neuron Facial Nerve Paralysis Following Recombinant Hepatitis B Vaccine Administration: A Case Report and Literature Review. [PDF]

Clin Case Rep
Ghouri RG, Naeem H, Yousaf MR, Sohail A, Arshad W, Basil AM.   +5 more
europepmc   +1 more source

One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis

, 2010
Daniele Di Paolo, Ilaria Lenci, C. Cerocchi, Laura Tariciotti, Andrea del Monaco, A. Brega, Laura Lotti, Giuseppe Tisone, M. Angélico   +8 more
openalex   +2 more sources

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, Volume 36, Issue 1, 2 January 2026.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source